Breaking News Instant updates and real-time market news.

NIO

NIO Inc.

$4.87

-0.14 (-2.79%)

, CVE

Cenovus Energy

$9.11

0.075 (0.83%)

07:35
05/07/19
05/07
07:35
05/07/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Monday in NIO Inc (NIO), Cenovus Energy (CVE), Macy's (M), Nike (NKE), Las Vegas Sands (LVS), AIG (AIG), Ctrip.com (CTRP), Infinera (INFN), Pareteum Corp (TEUM), and SQM (SQM).

NIO

NIO Inc.

$4.87

-0.14 (-2.79%)

CVE

Cenovus Energy

$9.11

0.075 (0.83%)

M

Macy's

$23.21

-0.035 (-0.15%)

NKE

Nike

$83.57

-2.165 (-2.53%)

LVS

Las Vegas Sands

$66.53

-1.92 (-2.81%)

AIG

AIG

$47.07

-0.02 (-0.04%)

CTRP

Ctrip

$41.96

-2.24 (-5.07%)

INFN

Infinera

$4.41

-0.01 (-0.23%)

TEUM

Pareteum

$5.18

0.39 (8.14%)

SQM

SQM

$36.36

0.1 (0.28%)

  • 07

    May

  • 07

    May

  • 08

    May

  • 15

    May

  • 15

    May

  • 16

    May

  • 17

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 30

    May

  • 24

    Jun

  • 25

    Jun

  • 25

    Jul

NIO NIO Inc.
$4.87

-0.14 (-2.79%)

04/04/19
SBSH
04/04/19
UPGRADE
Target $6.8
SBSH
Buy
NIO Inc. upgraded to Buy from Neutral at Citi
Citi analyst Jeff Chung upgraded NIO Inc. to Buy from Neutral while lowering his price target for the shares to $6.80 from $7.20.
04/04/19
BOFA
04/04/19
UPGRADE
Target $6.2
BOFA
Neutral
NIO Inc. upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst Ming Hsun Lee upgraded NIO Inc. to Neutral from Underperform with a price target of $6.20. The shares, after declining 47% from the peak in early March, have now factored in the company's lowered sales volume growth, Lee tells investors in a research note. The analyst views NIO's current valuation as fair and expects its volume sales to grow sequentially in Q2 relative to Q1. The company just launched a six-seater ES8, which should gain some popularity from consumers, says Lee. Further, NIO is arranging more test-drive events in more cities, which the analyst believes should help orders improve.
04/04/19
SBSH
04/04/19
UPGRADE
Target $6.8
SBSH
Buy
Citi upgrades NIO to Buy after 47% selloff since March peak
Citi analyst Jeff Chung upgraded NIO Inc. to Buy from Neutral while lowering his price target for the shares to $6.80 from $7.20. BofA/Merrill this morning also upgraded the shares to Neutral from Underperform. Chung is in part making a valuation call with the shares down 47% since the early-March peak. He also expects a valuation "re-rate" of China's electric vehicle sector. NIO's Q1 shipments beat consensus and ES6 deliveries, which start in early June, should be faster than consensus expects, Chung tells investors in a research note. The analyst also believes NIO's customer base is less price sensitive due to its premium brand positioning. Share of NIO are up 14c to $5.45 in premarket trading.
04/04/19
04/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Neutral at Guggenheim with analyst Michael Morris saying investors will continue to gain comfort with the incremental financial risk created by Facebook's content and privacy concerns. 2. NIO Inc. (NIO) upgraded to Buy from Neutral at Citi and to Neutral from Underperform at BofA/Merrill. 3. Ingersoll-Rand (IR) upgraded to Buy from Neutral at BofA/Merrill with analyst Andrew Obin citing premium core and earnings growth. 4. EOG Resources (EOG) upgraded to Buy from Hold at Tudor Pickering. 5. Signature Bank (SBNY) upgraded to Overweight from Neutral at JPMorgan with analyst Steven Alexopoulos raising his price target for the shares to $150 from $133. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CVE Cenovus Energy
$9.11

0.075 (0.83%)

04/23/19
SBSH
04/23/19
NO CHANGE
SBSH
Neutral
Citi opens '30-Day Upside Catalyst Watch' on Cenovus Energy
Citi analyst Prashant Rao opened a "30-Day Upside Catalyst Watch" on Neutral-rated Cenovus Energy. Stronger price realizations in the upstream due to higher benchmark oil prices and narrowed Canadian differentials could drive "meaningful upside" to Wednesday's Q1 results, Rao tells investors in a research note. The analyst also sees the potential for upward Q2 estimate revisions, helped by "bullish sentiment" for continued upstream price strength in the near-to-intermediate term.
04/16/19
GSCO
04/16/19
UPGRADE
Target $11
GSCO
Neutral
Cenovus Energy upgraded to Neutral with $11 price target at Goldman Sachs
Goldman Sachs analyst Neil Mehta upgraded Cenovus Energy (CVE) to Neutral from Sell and raised his price target for the shares to $11 from $7.50. The analyst cites improvements to the company's leverage outlook and a more constructive commodity price environment, particularly for Canadian heavy crude, for the upgrade. However, he stills see more upside to Buy-rated ConocoPhillips (COP), Canadian Natural Resources (CNQ), Suncor (SU) and Imperial Oil (IMO) among large cap North American oils than Cenovus.
04/16/19
GSCO
04/16/19
UPGRADE
GSCO
Neutral
Cenovus Energy upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Neil Mehta upgraded Cenovus Energy to Neutral from Sell.
04/16/19
04/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Buy from Hold at Deutsche Bank with analyst Bryan Kraft saying consensus subscriber expectations for both 2019 and 2020 now seem conservative. 2. Cenovus Energy (CVE) upgraded to Neutral from Sell at Goldman Sachs with analyst Neil Mehta citing improvements to the company's leverage outlook and a more constructive commodity price environment, particularly for Canadian heavy crude. 3. Cummins (CMI) upgraded to Buy from Neutral at Citi with analyst Timothy Thein saying he sees upside to 2019 estimates and thinks the company's out-year cash flows "stay higher for longer based on end market diversity and increasing contribution from the aftermarket." 4. Western Digital (WDC) upgraded to Buy from Hold at Deutsche Bank with analyst Sidney Ho starting to see favorable data points in both hard disk drive and NAND that will support a "solid" second half of the year recovery for Western Digital's earnings. 5. e.l.f. Beauty (ELF) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser citing the findings of her proprietary store checks suggesting that the company products have seen a 17% increase in shelf space at Target (TGT), overtaking Coty's (COTY) Covergirl brand, while its Q1 sales "inflected from down high-single digits" in Q4 to low-single digits. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
M Macy's
$23.21

-0.035 (-0.15%)

02/06/19
OTRG
02/06/19
DOWNGRADE
OTRG
Mixed
Macy's downgraded to Mixed from Positive at OTR Global
04/03/19
STPT
04/03/19
UPGRADE
STPT
Buy
Macy's upgraded to Buy from Hold at Standpoint Research
02/12/19
CLVD
02/12/19
NO CHANGE
CLVD
Macy's sales softened in January, says Cleveland Research
02/20/19
WEDB
02/20/19
NO CHANGE
Target $65
WEDB
Neutral
Dillard's price target lowered to $65 from $70 at Wedbush
Wedbush analyst Jen Redding lowered his price target for Dillard's (DDS) to $65 from $70 as she leans cautiously into earnings, with her data models showing revenues a touch below consensus, elevated e-commerce inventories, and lackluster consumer spending fueled by a late tax return season, likely compounding pressures for the beleaguered department store group. Though shares depreciated less than Macy's (M), Nordstrom (JWN), and Kohl's (KSS) for the period November 5 through January 31, the analyst attributes relative outperformance compared to the peer group as owing to Dillard's low profile presence on the street, and limited availability of data points versus investor expectations for an upcoming positive catalyst. Redding reiterates a Neutral rating on Dillard's shares.
NKE Nike
$83.57

-2.165 (-2.53%)

04/10/19
SBSH
04/10/19
INITIATION
Target $100
SBSH
Buy
Nike assumed with a Buy rating, $100 price target at Citi
Citi analyst Paul Lejuez assumed coverage of Nike from Kate McShane and kept a Buy rating on the shares. He raised his price target for the stock to $100 from $96. Nike is the dominant player in the global athletic footwear and apparel market, which is a "healthy and growing market buoyed by structural tailwinds," Lejuez tells investors in a research note.
04/10/19
SBSH
04/10/19
DOWNGRADE
Target $68
SBSH
Neutral
Foot Locker assumed with a Neutral from Buy at Citi
Citi analyst Paul Lejuez assumed coverage of Foot Locker (FL) from Kate McShane and downgraded the shares to Neutral from Buy. He also lowered his price target for the stock to $68 from $72. While Foot Locker has "tailwinds at its back" in North America with comps inflecting positively in Q4, the company still faces many of the same headwinds as other specialty retailers given its "significant" mall exposure and EBIT pressure from direct-to-consumer, Lejuez tells investors in a research note. He believes Nike's direct-to-consumer ambitions are a "secular headwind" for Foot Locker.
04/12/19
JEFF
04/12/19
NO CHANGE
JEFF
Under Armour discounts flat to down for 12th straight month, says Jefferies
Jefferies analyst Randal Konik says his firm's March webscrapes illustrate that Under Armour's (UAA) percentage of product on discount is flat to down for the twelfth month in a row year-over-year, Jefferies analyst Randal Konik tells investors in a research note. Further, the webscrapes show Adidas's (ADDYY) percentage of product on discount is up for the twelfth month in a row year-over-year, adds the analyst. In addition, visits to Finish Line (FINL), Foot Locker (FL), and Under Armour websites reveal the HOVR, Project Rock, and Curry 6 are sold out in several sizes, indicating strong demand, says Konik. He believes Nike (NKE) continues to dominate Adidas in running in the U.S., with strength in Air VaporMax and Air Max 270. The analyst also thinks the data bodes well for Under Armour's's sales and margins in Q1.
04/18/19
PIPR
04/18/19
NO CHANGE
Target $30
PIPR
Overweight
Under Armour Q1 expectations 'at least achievable,' says Piper Jaffray
Piper Jaffray analyst Erinn Murphy says her work year-to-date indicates generally well controlled inventory across the domestic athletic industry. Currently, Under Armour (UAA) online clearance styles are down 19% year-over-year versus Nike's (NKE) down 5% and Adidas' (ADDYY) up 96%. The analyst believes industry competition "should remain rational" during 2019. Further, Q1 consensus expectations for Under Armour are "at least achievable" and management should maintain fiscal 2019 guidance, Murphy tells investors in a pre-earnings research note. The analyst this quarter has seen on-going traction with HOVR's footwear platform, broader focus with Under Armour's women's and a well-supported launch of Rush. She keeps an Overweight rating on Under Armour shares with a $30 price target.
LVS Las Vegas Sands
$66.53

-1.92 (-2.81%)

04/18/19
STFL
04/18/19
NO CHANGE
Target $80
STFL
Buy
Las Vegas Sands price target raised to $80 from $72 at Stifel
Stifel analyst Steven Wieczynski raised his price target on Las Vegas Sands to $80 from $72, stating that the company "delivered another solid quarter" with "exceptional mass market gaming performance" in Macau and Singapore. However, while he expects shares to trade "modestly higher" following earnings, he does not see anything within the results or management's commentary capable of triggering a fundamental shift in the currently "decidedly mixed" sentiment on the stock. Wieczynski, who encourages investors to "look beyond the short-term noise," keeps a Buy rating on Las Vegas Sands shares.
04/18/19
DBAB
04/18/19
NO CHANGE
Target $69
DBAB
Hold
Las Vegas Sands price target raised to $69 from $60 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli raised his price target for Hold-rated Las Vegas Sands to $69 from $60 following the company's Q1 beat. The analyst views the report as "solid" but sees the stock's current valuation as "reasonable and fair."
04/18/19
JPMS
04/18/19
NO CHANGE
Target $71
JPMS
Neutral
Las Vegas Sands price target raised to $71 from $62 at JPMorgan
JPMorgan analyst Joseph Greff raised his price target for Las Vegas Sands (LVS) to $71 from $62 following the company's Q1 results. The analyst sees "lots of moving pieces" in the print and keeps a Neutral rating on the shares. Greff thinks there are reasons to be optimistic that the Macau market will rebound later in Q2 of Q3, but at current share levels, he sees more value and better risk/rewards in Wynn Resorts (WYNN) and Melco Resorts & Entertainment (MLCO).
04/17/19
HSBC
04/17/19
DOWNGRADE
Target $65.4
HSBC
Hold
HSBC downgrades Las Vegas Sands to Hold on valuation
HSBC analyst Charlene Liu downgraded Las Vegas Sands (LVS) to Hold from Buy and lowered her price target for the shares to $65.40 from $69.50. The analyst cites valuation for the downgrade and notes her new target implies 2% downside. Between Las Vegas Sands and Sands China (SCHYY), a stock Liu downgraded to Hold earlier this week, the analyst continues to prefer direct exposure to Macau through Las Vegas Sands' Hong Kong-listed subsidiary Sands China. She prefers Macau over Singapore for its "bigger market size and high growth potential." Liu maintains a Buy rating on Genting Singapore (GIGNY).
AIG AIG
$47.07

-0.02 (-0.04%)

02/15/19
COMP
02/15/19
UPGRADE
COMP
Buy
AIG upgraded to Buy from Neutral at Compass Point
02/15/19
ARGS
02/15/19
DOWNGRADE
ARGS
Hold
AIG downgraded to Hold from Buy at Argus
Argus analyst Jacob Kilstein downgraded AIG to Hold after its latest Q4 earnings miss driven by "catastrophe losses, large reserve charges, and poor investment results", saying the stock is consistently underperforming. The analyst believes that the company will continue to deal with "restructuring charges and higher-than-normal catastrophe losses", adding that while its price to book ratio of 0.6-times implies a discount to the peer industry average of 1.6-times, it is justified by its "below-average ROE and quarterly losses."
02/15/19
02/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Workday (WDAY) upgraded to Outperform from Market Perform at Cowen with analyst J. Derrick Wood saying his checks reveal a strong uptick in its pipeline of new blue chip Cloud financial customers and he believes it is ready to set off a new product cycle. 2. AIG (AIG) upgraded to Buy from Neutral at Compass Point. 3. Bloomin' Brands (BLMN) upgraded to Outperform from Market Perform at William Blair with analyst Sharon Zackfia saying he sees an "undemanding valuation" at current share levels as well as the potential for an operating margin recovery to add 200 basis points over the next three to four years. 4. Cedar Fair (FUN) upgraded to Outperform from Neutral at Macquarie. 5. Healthcare Trust (HTA) upgraded to Overweight from Equalweight at Capital One. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/21/19
UBSW
02/21/19
NO CHANGE
Target $52
UBSW
Buy
AIG at inflection despite disappointing Q4 results, says UBS
UBS analyst Brian Meredith said despite AIG's disappointing Q4 results, management reiterated their expectation that the General Insurance segment would achieve a profit in Q1. The analyst also said the benefit coming from their reinsurance strategy in 2019 is underappreciated by the market. He believes management's guidance of margin expansion from a rate and mix shift will be challenging to achieve, so he modeled in half of the guidance only. Meredith maintained his Buy rating and $52 price target on AIG shares.
CTRP Ctrip
$41.96

-2.24 (-5.07%)

04/15/19
DBAB
04/15/19
NO CHANGE
DBAB
Ctrip added as catalyst call Buy at Deutsche Bank
05/07/19
MZHO
05/07/19
UPGRADE
Target $55
MZHO
Buy
Mizuho upgrades Ctrip to Buy with $55 price target into Q1 results
Mizuho analyst James Lee last night upgraded Ctrip (CTRP) to Buy from Neutral and raised his price target for the shares to $55 from $35 ahead of the company's Q1 results. The analyst expects decreased competition along with an improved macro environment and yuan appreciation will drive both domestic and outbound travel. As such, he raised his three-year annual EBITDA growth estimate for Ctrip to 35% from 23% on improved long-term fundamentals. Alibaba (BABA) remains Lee's top pick in the China Internet space.
05/06/19
MZHO
05/06/19
UPGRADE
MZHO
Buy
Ctrip upgraded to Buy from Neutral at Mizuho
05/03/19
MACQ
05/03/19
DOWNGRADE
MACQ
Neutral
Ctrip downgraded to Neutral from Outperform at Macquarie
INFN Infinera
$4.41

-0.01 (-0.23%)

05/07/19
PIPR
05/07/19
NO CHANGE
Target $69
PIPR
Overweight
Fabrinet target raised to $69 on 'impressive' results at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for Fabrinet (FN) to $69 from $67 saying the company reported "impressive" March quarter results with revenue and earnings "comfortably" beating consensus expectations. Demand for telco optics remained strong in the quarter and the company is now turning modestly more upbeat regarding second half of the year strength for datacom optics, Jensen tells investors in a research note. Further, Fabrinet also announced a material win with Infinera (INFN), adds the analyst. He reiterates an Overweight rating on the shares.
03/28/19
UBSW
03/28/19
NO CHANGE
Target $64
UBSW
Buy
Acacia Communications price target raised to $64 from $56 at UBS
UBS analyst Tejas Venkatesh raised his price target on Acacia Communications (ACIA) to $64 and kept his Buy rating, citing his increased confidence in the company's growth. The analyst points to the company's "concurrent product cycles" being in the early stages, its rising cloud market content, and its "new data center interconnect customers like Cisco (CSCO) and Infinera (INFN)". Venkatesh contends that Acacia Communications can achieve 2019 EPS of $1.80 vs. the current consensus of $1.50.
03/27/19
MSCO
03/27/19
NO CHANGE
MSCO
Morgan Stanley upgrades Lumentum, downgrades Acacia in optical ratings shake up
As previously reported, Morgan Stanley analyst Meta Marshall upgraded Lumentum (LITE) to Overweight from Equal Weight and downgraded Acacia Communications (ACIA) to Underweight from Equal Weight as she believes thematic transitions in the optical sector are being misvalued in the market. On Lumentum, she thinks 3D sensing estimates should be reset and believes the remainder of the year presents more opportunity for upside. Marshall raised her price target on Lumentum shares to $65 from $55. On Acacia, Marshall thinks investors are over-extrapolating its earnings power and not assigning enough risk to customer concentration. However, the analyst raised her price target on Acacia shares to $44 from $38, noting that she is early with her downgrade and believes the company could "post meaningful beats" in the next 6-9 months. Outside of these two outlier ratings, Marshall has an Equal Weight rating on optical components providers Infinera (INFN), II-VI (IIVI) and Ciena (CIEN).
03/11/19
MKMP
03/11/19
UPGRADE
Target $6
MKMP
Buy
Infinera upgraded to Buy from Neutral at MKM Partners
MKM Partners analyst Michael Genovese upgraded Infinera to Buy from Neutral with a $6 price target following a "very upbeat" meeting with the company's CFO in San Diego last week. In a research note to investors, Genovese says it sounds like Infinera's order book, new wins and pipeline have all significantly improved recently and thinks the risk-reward for 2019 is skewed very positively with little downside on misses and a lot of upside if the company makes this year's numbers. The stock is very inexpensive, Genovese contends, and says fundamentals should be steadily improving in 2019.
TEUM Pareteum
$5.18

0.39 (8.14%)

02/15/19
NORL
02/15/19
NO CHANGE
Target $7.5
NORL
Outperform
Pareteum backlog announcement increases Northland confidence in estimates
After Pareteum announced continued increases in its 3-year backlog yesterday, Northland analyst Michael Latimore said the company's announcement gives him more confidence in his estimates. The analyst, who noted that the recently complete iPass acquisition gives Pareteum 100 more people to help deploy backlog, keeps an Outperform rating and $7.50 price target on the stock.
04/26/19
OPCO
04/26/19
INITIATION
Target $7
OPCO
Outperform
Oppenheimer sees above 30% revenue growth for Pareteum, starts at Outperform
Oppenheimer analyst Timothy Horan last night initiated coverage of Pareteum with an Outperform rating and $7 price target. Pareteum has a software solution for enabling mobile virtual network operators, Internet of Things and applications on one network/cloud, Horan tells investors in a research note. The analyst believes the company can grow revenues above 30% for the next five years and ultimately double its 15% EBITDA margins. There are high barriers to entry to its integrated service, and most competitors have major channel conflicts, Horan contends. Further, Pareteum's backlog has seen "very strong growth" in the last few quarters, providing visibility on revenue growth, he adds.
04/25/19
OPCO
04/25/19
INITIATION
Target $7
OPCO
Outperform
Pareteum initiated with an Outperform at Oppenheimer
Oppenheimer analyst Timothy Horan started Pareteum with an Outperform rating and $7 price target.
02/19/19
NORL
02/19/19
NO CHANGE
Target $7.5
NORL
Outperform
Pareteum 'undervalued' following January wins, says Northland
Northland analyst Michael Latimore notes that Pareteum announced on Friday 12 wins in the month of January. The analyst likes that the company is winning more U.S.-based customers, and argues that the wins and associated increase in backlog give him more confidence in his estimates. Overall, Latimore believes Pareteum is undervalued, trading at only 3.76 times his FY19 revenue estimates and 2.93 times FY20. He reiterates an Outperform rating and $7.50 price target on the shares.
SQM SQM
$36.36

0.1 (0.28%)

04/15/19
SBSH
04/15/19
DOWNGRADE
Target $13
SBSH
Neutral
Citi sees lithium as 'buyer's market,' downgrades Livent to Neutral from Buy
Citi analyst P.J. Juvekar downgraded Livent (LTHM) to Neutral from Buy and lowered his price target for the shares to $13 from $15. The analyst also reduced his price target for Neutral-rated Albemarle (ALB) to $88 from $92. Following a site visit to the Salar de Atacama and meetings with SQM's (SQM) CFO, Juvekar gets the sense that the lithium market "has become a buyer's market." Chinese buyers seem to have become more aggressive and China's new energy vehicle subsidy cuts may weigh on the market beginning in the second half of 2019, the analyst tells investors in a research note. While Albemarle and Livent's volumes are secured under multi-year terms, pricing for future volumes could come under pressure as new conversion capacity ramps up in 2019-2020, contends Juvekar. He reduced his valuation multiples for both stocks as "competition in the lithium market increases."
04/22/19
VERF
04/22/19
INITIATION
Target $23
VERF
Sell
SQM initiated with a Sell at Vertical Group
Vertical Group analyst James Bardowski started SQM with a Sell rating and $23 price target. The company has relatively high exposure to lithium spot markets, where prices are at risk of moving lower as supply outpaces demand near-term and an end to China's new energy vehicles subsidies comes into sight, Bardowski tells investors in a research note. Further, increased spending at SQM "will stretch an already limited balance sheet," adds the analyst.
04/23/19
04/23/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Roku (ROKU) initiated with a Positive at Susquehanna. 2. Zosano Pharma (ZSAN) initiated with an Overweight at Cantor Fitzgerald. 3. Trade Desk (TTD) initiated with a Hold at Needham. 4. SQM (SQM) initiated with a Sell at Vertical Group. 5. Lyft (LYFT) initiated with an Outperform at JMP Securities, Raymond James, Cowen, and Credit Suisse, an Overweight at JPMorgan and Piper Jaffray, a Buy at Jefferies, Canaccord, and Stifel, and a Sector Weight at KeyBanc. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/19
MSCO
04/12/19
NO CHANGE
Target $35
MSCO
Underweight
SQM price target lowered to $35 from $44 at Morgan Stanley
Morgan Stanley analyst Javier Martinez de Olcoz Cerdan cut his price target on SQM (SQM) shares to $35 from $44 and keeps an Underweight rating on the stock after meeting with the company's new CEO, Corfo, the ministry of mining and other industry contacts in Chile. Following his visit, he is less optimistic about both the possibility of an early lease renewal and the pace of SQM's medium-term expansion, he said, adding that he sees significant potential downside to SQM's consensus forecasts. The analyst continue to see downside to consensus lithium price expectations and also keeps an Underweight rating on Albemarle (ALB).

TODAY'S FREE FLY STORIES

06:45
05/27/19
05/27
06:45
05/27/19
06:45
General news
European stock marked moved broadly higher »

European stock marked…

05:50
05/27/19
05/27
05:50
05/27/19
05:50
General news
FX Update: Conditions have been thin »

FX Update: Conditions…

03:30
05/27/19
05/27
03:30
05/27/19
03:30
General news
FX Action: USD-CAD has settled in the mid 1.3400s »

FX Action: USD-CAD has…

03:00
05/27/19
05/27
03:00
05/27/19
03:00
General news
FX Update: Risk-off positioning have unwound some more in the forex markets »

FX Update: Risk-off…

02:35
05/27/19
05/27
02:35
05/27/19
02:35
General news
Asian Market Wrap: »

Asian Market Wrap:…

TEVA

Teva

$10.86

-0.18 (-1.63%)

12:11
05/26/19
05/26
12:11
05/26/19
12:11
Hot Stocks
Teva reaches $85M agreement with State of Oklahoma »

Teva Pharmaceuticals USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLT

Elbit Systems

$141.85

1.33 (0.95%)

12:08
05/26/19
05/26
12:08
05/26/19
12:08
Hot Stocks
Elbit Systems awarded $127M contract to provide tactical radio system »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ADM

Archer Daniels

$39.17

-0.03 (-0.08%)

12:05
05/26/19
05/26
12:05
05/26/19
12:05
Hot Stocks
Archer Daniels expands recall of Baker's Corner All Purpose Flour 5lb bags »

ADM Milling is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

JCP

J.C. Penney

$0.93

0.022 (2.42%)

, DDS

Dillard's

$56.57

0.25 (0.44%)

13:29
05/25/19
05/25
13:29
05/25/19
13:29
Periodicals
Target stock triumphs in brutal week for retail, Barron's says »

Earnings season has been…

JCP

J.C. Penney

$0.93

0.022 (2.42%)

DDS

Dillard's

$56.57

0.25 (0.44%)

KSS

Kohl's

$51.11

-0.04 (-0.08%)

JWN

Nordstrom

$33.50

-0.31 (-0.92%)

M

Macy's

$21.00

-0.27 (-1.27%)

TGT

Target

$81.57

2.17 (2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

JPM

JPMorgan

$109.78

1.14 (1.05%)

, AKZOY

AkzoNobel

$0.00

(0.00%)

13:24
05/25/19
05/25
13:24
05/25/19
13:24
Periodicals
Microsoft, JPMorgan among dividend champions, Barron's says »

Among the companies that…

JPM

JPMorgan

$109.78

1.14 (1.05%)

AKZOY

AkzoNobel

$0.00

(0.00%)

XOM

Exxon Mobil

$74.12

0.33 (0.45%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

CMWAY

Commonwealth Bank of Australia

$0.00

(0.00%)

SIEGY

Siemens

$0.00

(0.00%)

T

AT&T

$32.29

0.15 (0.47%)

RDS.A

Royal Dutch Shell

$63.29

0.84 (1.35%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$87.49

3.03 (3.59%)

BHP

BHP Group

$52.47

1.18 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 29

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 11

    Jun

  • 12

    Jun

  • 20

    Jun

  • 23

    Jun

  • 16

    Jul

  • 24

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

GM

General Motors

$35.13

0.01 (0.03%)

, TSLA

Tesla

$190.80

-4.7 (-2.40%)

13:19
05/25/19
05/25
13:19
05/25/19
13:19
Periodicals
Tesla stock in trouble, Barron's says »

Tesla (TSLA) stock is the…

GM

General Motors

$35.13

0.01 (0.03%)

TSLA

Tesla

$190.80

-4.7 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 11

    Jun

  • 01

    Aug

RNLSY

Renault

$0.00

(0.00%)

13:14
05/25/19
05/25
13:14
05/25/19
13:14
Periodicals
Renault stock may rally, Barron's says »

Shares of French auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

, DWDP

DowDuPont

$31.10

0.16 (0.52%)

13:11
05/25/19
05/25
13:11
05/25/19
13:11
Periodicals
DowDuPont spinoff a new agriculture stock, FMC safer bet, Barron's says »

The crop-protection and…

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

DWDP

DowDuPont

$31.10

0.16 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 25

    Jun

MGM

MGM Resorts

$25.55

0.19 (0.75%)

13:03
05/25/19
05/25
13:03
05/25/19
13:03
Periodicals
MGM Resorts looks like an attractive gambling play, Barron's says »

MGM Resorts (MGM) stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PYPL

PayPal

$109.82

-0.09 (-0.08%)

, AXP

American Express

$119.52

1.07 (0.90%)

12:30
05/25/19
05/25
12:30
05/25/19
12:30
Periodicals
Big tech failed to dethrone credit cards, Barron's says »

Rather than being cut out…

PYPL

PayPal

$109.82

-0.09 (-0.08%)

AXP

American Express

$119.52

1.07 (0.90%)

MA

MasterCard

$251.40

1.57 (0.63%)

V

Visa

$162.72

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 06

    Jun

  • 11

    Jun

  • 25

    Jun

  • 13

    Nov

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

, GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

07:20
05/25/19
05/25
07:20
05/25/19
07:20
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

AMBA

Ambarella

$38.28

1.07 (2.88%)

ON

ON Semiconductor

$17.68

-0.235 (-1.31%)

NKE

Nike

$82.12

-0.51 (-0.62%)

ADDYY

Adidas

$0.00

(0.00%)

UAA

Under Armour

$23.54

0.075 (0.32%)

UA

Under Armour

$20.91

0.08 (0.38%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

VMC

Vulcan Materials

$126.28

1.25 (1.00%)

FLR

Fluor

$29.04

0.18 (0.62%)

ACM

Aecom

$31.56

-0.03 (-0.09%)

X

U.S. Steel

$13.63

-0.08 (-0.58%)

AKS

AK Steel

$2.00

-0.155 (-7.21%)

NUE

Nucor

$51.12

-0.27 (-0.53%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$12.85

0.11 (0.86%)

F

Ford

$9.83

-0.02 (-0.20%)

GM

General Motors

$35.13

0.01 (0.03%)

HMC

Honda

$25.45

0.175 (0.69%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.54

1.16 (0.99%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.